Microfluidic synthesis of [177Lu]Lu-DOTA-TATE

被引：0
|
作者：
Liu, Zheng [1 ]
Schaap, Kevin [1 ]
Rohde, Martin [1 ]
Oehlke, Elisabeth [1 ]
机构：
[1] Delft Univ Technol, Radiat Sci & Technol, Delft, Netherlands
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
P 294
引用
收藏
页码：S462 / S462
页数：1
相关论文
共 50 条
  • [21] S-phase enrichment by hydroxyurea treatment enhances [177Lu]Lu-DOTA-TATE uptake in vitro
    Cheng, J.
    Livieratos, L.
    Terry, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S57 - S57
  • [22] Navigating nephrotoxicity: insights from 4 years of [177Lu]Lu-DOTA-TATE therapy at our institution
    Sousa, E.
    Sousa, R.
    Fraga, D.
    Carvalho, I. P.
    Vitorino, I.
    Rombo, D.
    Aco, J.
    Jorge, P.
    Salgado, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S667 - S667
  • [23] Efficacy of [177Lu]Lu-DOTA-TATE in metastatic neuroendocrine neoplasms of different locations: our experience.
    Pudis, M.
    Vercher-Conejero, J. L.
    Martin-Marcuartu, J. J.
    Teule-Vega, A.
    Bondia-Bescos, S.
    Hervas-Sanz, B.
    Rodriguez-Gasen, A.
    Diaz-Moreno, J.
    Cortes-Romera, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S647 - S647
  • [24] Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [177Lu]Lu-OPS201 Compared to the Agonist [177Lu]Lu-DOTA-TATE
    Mansi, Rosalba
    Plas, Pascale
    Vauquelin, Georges
    Fani, Melpomeni
    PHARMACEUTICALS, 2021, 14 (12)
  • [25] Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry
    Riveira-Martin, Mercedes
    Struelens, Lara
    Iglesias, Jose Munoz
    Schoonjans, Werner
    Tabuenca, Olga
    Nogueiras, Jose Manuel
    Gomez, Francisco Javier Salvador
    Medina, Antonio Lopez
    EJNMMI PHYSICS, 2023, 10 (01)
  • [26] Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry
    Mercedes Riveira-Martin
    Lara Struelens
    José Muñoz Iglesias
    Werner Schoonjans
    Olga Tabuenca
    José Manuel Nogueiras
    Francisco Javier Salvador Gómez
    Antonio López Medina
    EJNMMI Physics, 10
  • [27] A PBPK model for PRRT with [177Lu]Lu-DOTA-TATE: Comparison of model implementations in SAAM II and MATLAB/SimBiology
    Vasic, Valentina
    Gustafsson, Johan
    Nowshahr, Elham Yousefzadeh
    Stenvall, Anna
    Beer, Ambros J.
    Glatting, Gerhard
    Gleisner, Katarina Sjogreen
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 119
  • [28] Efficacy of the personalized, dosimetry-based PRRT treatment of patients with neuroendocrine tumors using [177Lu]Lu-DOTA-TATE or [177Lu]/[90Y]Lu/Y-DOTA-TATE mixture - the DUONEN multicenter study
    Opalinska, M.
    Mikolajczak, R.
    Kaminski, G.
    Dedecjus, M.
    Kowalska, A.
    Kolodziej, M.
    Saracyn, M.
    Garnuszek, P.
    Cieszykowska, I.
    Sowa-Staszczak, A.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S369 - S369
  • [29] Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours
    Geenen, Lorain
    Nonnekens, Julie
    Konijnenberg, Mark
    Baatout, Sarah
    De Jong, Marion
    Aerts, An
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 102 : 1 - 11
  • [30] Assessment of Occupational Radiation Exposure During Administration of [177Lu]Lu-DOTA-TATE Using Active and Passive Dosimetry
    Riveira-Martin, M.
    Struelens, L.
    Iglesias, J. Munoz
    Schoonjans, W.
    Alonso, J. M. Nogueiras
    Tabuenca, O.
    Gomez, F. J. Salvador
    Medina, A. Lopez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S226 - S227
12345